SEC Comment Letter 0000000000-23-004694 to BELITE BIO, INC (BLTE) (CIK 0001889109) (BLTE)
BELITE BIO, INC (BLTE) (CIK 0001889109)
Date: May 5, 2023 · CIK: 0001889109 · Accession: 0000000000-23-004694
AI Filing Summary & Sentiment
File numbers found in text: 333-271549
Letter
United States securities and exchange commission logo May 5, 2023 Hao-Yuan Chuang Chief Financial Officer BELITE BIO, INC 12750 High Bluff Drive Suite 475 San Diego, CA 92130 Re:BELITE BIO, INC Registration Statement on Form F-3 Filed May 1, 2023 File No. 333-271549 Dear Hao-Yuan Chuang: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Portia Ku
Show Raw Text
United States securities and exchange commission logo
May 5, 2023
Hao-Yuan Chuang
Chief Financial Officer
BELITE BIO, INC
12750 High Bluff Drive Suite 475
San Diego, CA 92130
Re:BELITE BIO, INC
Registration Statement on Form F-3
Filed May 1, 2023
File No. 333-271549
Dear Hao-Yuan Chuang:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Portia Ku